Speciality Molecules Ventures Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Struck Off
Last Updated:
About Speciality Molecules Ventures Private Limited

Speciality Molecules Ventures Private Limited, a struck off private limited company, was established on 26 May 2017 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24290MH2017PTC295450. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Rajendra Manohar Gogate (Director), Aniruddha Anil Andhorikar (Director). It is based at 605 Bldg 15 Mass Hsg Project H No 42 H No 3Cts Vlg Majas Jogeshwari, Near Majaswadi Mahakal, I Road, Mumbai, Maharashtra, 400060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2017PTC295450

  • Registration Number

    295450

  • Incorporation Date

    26 May 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 9 Months
Company report

Speciality Molecules Ventures Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Speciality Molecules Ventures Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Speciality Molecules Ventures Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajendra Manohar Gogate Director 26 May 2017 Current
Aniruddha Anil Andhorikar Director 26 May 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Speciality Molecules Ventures.

Enhance accessibility to Speciality Molecules Ventures's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Speciality Molecules Ventures revenue growth over time
Speciality Molecules Ventures profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Speciality Molecules Ventures?

Unlock access to Speciality Molecules Ventures's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Speciality Molecules Ventures?

Unlock and access historical data on people associated with Speciality Molecules Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Speciality Molecules Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speciality Molecules Ventures's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Speciality Molecules Ventures
Recent Activity within the Organization
  • Director Appointment

    The activity Rajendra Manohar Gogate was appointed as a Director was appointed as a Director on 26 May 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    Progress on Aniruddha Anil Andhorikar was appointed as a Director was appointed as a Director on 26 May 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Company Incorporation

    Speciality Molecules Ventures Private Limited was registered on 26 May 2017 with Roc Mumbai & aged 8 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Speciality Molecules Ventures Private Limited?

The CIN of Speciality Molecules Ventures Private Limited is U24290MH2017PTC295450.

Where is Speciality Molecules Ventures Private Limited headquartered?

Speciality Molecules Ventures Private Limited is headquartered at 605 Bldg 15 Mass Hsg Project H No 42 H No 3Cts Vlg Majas Jogeshwari, Near Majaswadi Mahakal, I Road, Mumbai, Maharashtra, 400060.

When was Speciality Molecules Ventures Private Limited incorporated?

Speciality Molecules Ventures Private Limited was incorporated on 26 May 2017.

Who are the current directors of Speciality Molecules Ventures Private Limited?

The current directors of Speciality Molecules Ventures Private Limited are

What is the primary industry of Speciality Molecules Ventures Private Limited?

The primary industry of Speciality Molecules Ventures Private Limited is Chemicals.

Is Speciality Molecules Ventures Private Limited a listed company?

Speciality Molecules Ventures Private Limited is unlisted.

What is the capital structure of Speciality Molecules Ventures Private Limited?

The authorized capital of Speciality Molecules Ventures Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Speciality Molecules Ventures Private Limited?

The compliance status of Speciality Molecules Ventures Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available